Ignite Creation Date:
2025-12-24 @ 3:56 PM
Ignite Modification Date:
2026-02-03 @ 3:59 PM
Study NCT ID:
NCT01600092
Status:
COMPLETED
Last Update Posted:
2018-11-14
First Post:
2012-05-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of the Immunogenicity, Tolerability, and Safety of a New Formulation of RotaTeq™ in Infants (V260-035)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Rotavirus Gastroenteritis | View |
Keywords: